1. P3‐032: Identification of Predictors of Disease Progression in an Amyloid‐Beta 42 (Aβ42)‐Positive, Prodromal Alzheimer's Disease Cohort: Analysis of the Scarlet Road Study. (1st July 2016) Authors: Sun, Shuguang; Model, Fabian; Nikolcheva, Tania; Lasser, Robert A. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 17 Page Start: P829 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P4‐014: ESTIMAND IN EARLY ALZHEIMER'S DISEASE: PROGRESS UPDATE FROM THE INTERNATIONAL ALZHEIMER'S DISEASE SCIENTIFIC WORKING GROUP (AD SWG) SUBSTREAM. (1st July 2006) Authors: Delmar, Paul; Voyle, Nicola; Caputo, Angelika; Donohue, Michael C.; Li, David Jianjun; Mackey, Howard; Quarg, Peter; Zhu, Ying; Bell, James; Model, Fabian; Liu-Seifert, Hong Journal: Alzheimer's & dementia Issue: Volume 14:Supplement 7(2018)Part 27 Page Start: P1437 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 178 Long-term efficacy of ocrelizumab in relapsing multiple sclerosis. Issue 12 (14th November 2019) Authors: Giovannoni, Gavin; Hauser, Stephen L; Brochet, Bruno; Montalban, Xavier; Naismith, Robert T; Wolinsky, Jerry S; Hubeaux, Stanislas; Mehta, Lahar; Model, Fabian; Kappos, Ludwig Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 90:Issue 12(2019) Page Start: e47 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Initiation of symptomatic medication in Alzheimer's disease clinical trials: Hypothetical versus treatment policy approach. Issue 5 (8th April 2020) Authors: Donohue, Michael C.; Model, Fabian; Delmar, Paul; Volye, Nicola; Liu‐Seifert, Hong; Rafii, Michael S.; Aisen, Paul S. Journal: Alzheimer's & dementia Issue: Volume 16:Issue 5(2020) Page Start: 797 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Preliminary results of the opera i and opera ii open-label extension study. Issue 5 (8th May 2017) Authors: Naismith, Robert; Cascione, Mark; Grimaldi, Luigi; Hauser, Stephen; Kappos, Ludwig; Montalban, Xavier; Wolinsky, Jerry; Chin, Peter; Garren, Hideki; Julian, Laura; Model, Fabian; Honeycutt, David Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 88:Issue 5(2017) Page Start: e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO. Issue 6 (7th December 2020) Authors: Gibiansky, Ekaterina; Petry, Claire; Mercier, Francois; Günther, Andreas; Herman, Ann; Kappos, Ludwig; Hauser, Stephen; Yamamoto, Yumi; Wang, Qing; Model, Fabian; Kletzl, Heidemarie Journal: British journal of clinical pharmacology Issue: Volume 87:Issue 6(2021) Page Start: 2511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Recurrent disability progression endpoints in multiple sclerosis clinical trials. (January 2023) Authors: Bühler, Alexandra; Wolbers, Marcel; Model, Fabian; Wang, Qing; Belachew, Shibeshih; Manfrini, Marianna; Lorscheider, Johannes; Kappos, Ludwig; Beyersmann, Jan Journal: Multiple sclerosis Issue: Volume 29:Number 1(2023) Page Start: 130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 061 Ocrelizumab reduces disability progression independent of relapse activity in patients with relapsing multiple sclerosis (RMS) (ENCORE). Issue 6 (24th May 2018) Authors: Kappos, Ludwig; Wolinsky, Jerry S; Giovannoni, Gavin; Arnold, Douglas L; Lublin, Fred; Wang, Qing; Model, Fabian; Wei, Wei; Garren, Hideki; Manfrini, Marianna; Belachew, Shibeshih; Hauser, Stephen Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 89:Issue 6(2018) Page Start: A25 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension. (29th September 2020) Authors: Hauser, Stephen L.; Kappos, Ludwig; Arnold, Douglas L.; Bar-Or, Amit; Brochet, Bruno; Naismith, Robert T.; Traboulsee, Anthony; Wolinsky, Jerry S.; Belachew, Shibeshih; Koendgen, Harold; Levesque, Victoria; Manfrini, Marianna; Model, Fabian; Hubeaux, Stanislas; Mehta, Lahar; Montalban, Xavier Journal: Neurology Issue: Volume 95:Number 13(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. O4‐05‐05: Free and Cued Selective Reminding Test as an Inclusion Criterion for Early Alzheimer's Disease Clinical Trial Populations. (1st July 2016) Authors: Smith, Janice; Edgar, Chris J.; Lasser, Robert A.; Sun, Shuguang; Model, Fabian; Blaettler, Thomas Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 7 Page Start: P343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗